{"date":"2025-03-12","count":70,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6589-2025-03-12-2014-136u4yx","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"20:14:43","subject":"本公司研發中產品EG1206A（pertuzumab生物相似藥）獲得台灣衛生福利部食品藥物管理局(TFDA)同意進行第三期臨床試驗","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-03-12 20:14，「本公司研發中產品EG1206A（pertuzumab生物相似藥）獲得台灣衛生福利部食品藥物管理局(TFDA)同意進行第三」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-03-12-2012-ji61sl","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"20:12:56","subject":"本公司於114年01月01日起變動會計估計事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-03-12 20:12，「本公司於114年01月01日起變動會計估計事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-03-12-2007-1mi9058","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"20:07:43","subject":"本公司董事會決議召開114年股東常會(召開方式：視訊輔助股東會)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-03-12 20:07，「本公司董事會決議召開114年股東常會(召開方式：視訊輔助股東會)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-03-12-2002-13hmrqq","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"20:02:49","subject":"本公司董事會決議以私募發行有價證券辦理募資","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-03-12 20:02，「本公司董事會決議以私募發行有價證券辦理募資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-03-12-1956-j76elb","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"19:56:27","subject":"本公司董事會決議不繼續辦理113年股東常會通過之私募有價證券案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-03-12 19:56，「本公司董事會決議不繼續辦理113年股東常會通過之私募有價證券案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-03-12-1953-1geydxu","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"19:53:26","subject":"本公司董事會決議發行114年第1次限制員工權利新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-03-12 19:53，「本公司董事會決議發行114年第1次限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2025-03-12-1952-bwopfv","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"19:52:58","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2025-03-12","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2025-03-12 19:52，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-03-12-1951-md303j","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"19:51:32","subject":"本公司董事會決議不予分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-03-12 19:51，「本公司董事會決議不予分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6589-2025-03-12-1944-1qq5da5","company_id":"6589","company":"台康生技","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"19:44:31","subject":"本公司民國113年度合併財務報告業經董事會通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台康生技（6589），2025-03-12 19:44，「本公司民國113年度合併財務報告業經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2025-03-12-1900-xvke1e","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"19:00:21","subject":"公告本公司董事會決議召開114年股東會常會相關事宜","clause":"第32款","fact_date":"2025-03-12","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2025-03-12 19:00，「公告本公司董事會決議召開114年股東會常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2025-03-12-1848-1hku5w3","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"18:48:48","subject":"公告本公司董事會通過113年度合併財務報告","clause":"第43款","fact_date":"2025-03-12","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2025-03-12 18:48，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-03-12-1846-6r49ey","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"18:46:27","subject":"公告本公司董事會決議虧損撥補案暨不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-03-12 18:46，「公告本公司董事會決議虧損撥補案暨不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-03-12-1839-tulf6t","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"18:39:10","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-03-12 18:39，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-03-12-1838-yk0q3d","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"18:38:42","subject":"公告本公司113年度累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-03-12 18:38，「公告本公司113年度累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7427-2025-03-12-1838-kmy10s","company_id":"7427","company":"華上生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"18:38:16","subject":"公告本公司董事會通過113年度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：華上生醫（7427），2025-03-12 18:38，「公告本公司董事會通過113年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-03-12-1750-zyqcz8","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"17:50:33","subject":"公告本公司董事會決議辦理113年度第一次私募普通股定價及增資基準日等相關事宜","clause":"第11款","fact_date":"2025-03-12","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-03-12 17:50，「公告本公司董事會決議辦理113年度第一次私募普通股定價及增資基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-03-12-1749-1g7c29d","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"17:49:38","subject":"公告本公司董事會決議召開114年股東常會事宜","clause":"第17款","fact_date":"2025-03-12","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-03-12 17:49，「公告本公司董事會決議召開114年股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-03-12-1748-1jqlr5o","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"17:48:50","subject":"公告本公司董事會通過113年第4季合併財務報告","clause":"第31款","fact_date":"2025-03-12","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-03-12 17:48，「公告本公司董事會通過113年第4季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-03-12-1746-2iz4hx","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"17:46:52","subject":"公告本公司董事會決議不發放股利","clause":"第14款","fact_date":"2025-03-12","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-03-12 17:46，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2025-03-12-1744-11wjw0o","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"17:44:55","subject":"公告本公司董事會決議股利分派","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-03-12 17:44，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2025-03-12-1744-1mvy42n","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"17:44:09","subject":"公告本公司董事會決議股利分派情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2025-03-12 17:44，「公告本公司董事會決議股利分派情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2025-03-12-1740-812zd1","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"17:40:22","subject":"公告本公司董事會解除經理人競業行為限制","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2025-03-12 17:40，「公告本公司董事會解除經理人競業行為限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2025-03-12-1739-tulf6t","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"17:39:10","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2025-03-12 17:39，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2025-03-12-1736-1qnfv89","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"17:36:57","subject":"公告本公司董事會通過113年度合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2025-03-12 17:36，「公告本公司董事會通過113年度合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2025-03-12-1735-p8zct7","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"17:35:01","subject":"本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-03-12 17:35，「本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2025-03-12-1734-hrmqwp","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"17:34:27","subject":"公告本公司董事會決議資本公積轉增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-03-12 17:34，「公告本公司董事會決議資本公積轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6796-2025-03-12-1733-1hku5w3","company_id":"6796","company":"晉弘","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"17:33:57","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：晉弘（6796），2025-03-12 17:33，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4724-2025-03-12-1733-jj1qkt","company_id":"4724","company":"宣捷幹細胞","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"17:33:52","subject":"代子公司育禾管理顧問股份有限公司公告取得使用權資產","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：宣捷幹細胞（4724），2025-03-12 17:33，「代子公司育禾管理顧問股份有限公司公告取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-03-12-1731-1v2u3et","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"17:31:51","subject":"公告本公司董事會決議113年度盈餘分派案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-03-12 17:31，「公告本公司董事會決議113年度盈餘分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-03-12-1721-7l9f4u","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"17:21:31","subject":"公告本公司董事會決議召開113年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-03-12 17:21，「公告本公司董事會決議召開113年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-03-12-1720-hrmqwp","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"17:20:58","subject":"公告本公司董事會決議資本公積轉增資發行新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-03-12 17:20，「公告本公司董事會決議資本公積轉增資發行新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-03-12-1720-10554si","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"17:20:38","subject":"公告本公司董事會決議盈餘及資本公積分配情形","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-03-12 17:20，「公告本公司董事會決議盈餘及資本公積分配情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-03-12-1720-1ihoft2","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"17:20:19","subject":"本公司董事會決議召開114年股東常會事宜(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-03-12 17:20，「本公司董事會決議召開114年股東常會事宜(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-03-12-1719-1dm9ttd","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"17:19:56","subject":"公告本公司董事會通過113年度自結合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-03-12 17:19，「公告本公司董事會通過113年度自結合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-03-12-1712-kmy10s","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"17:12:50","subject":"公告本公司董事會通過113年度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-03-12 17:12，「公告本公司董事會通過113年度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-03-12-1711-2iz4hx","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"17:11:59","subject":"公告本公司董事會決議不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-03-12 17:11，「公告本公司董事會決議不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2025-03-12-1704-5ici0y","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"17:04:19","subject":"本公司董事會決議發行限制員工權利新股案","clause":"第9款","fact_date":"2025-03-12","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2025-03-12 17:04，「本公司董事會決議發行限制員工權利新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2025-03-12-1653-1hsk3vq","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"16:53:01","subject":"公告本公司董事會決議通過113年度財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2025-03-12 16:53，「公告本公司董事會決議通過113年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2025-03-12-1649-tulf6t","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"16:49:32","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2025-03-12 16:49，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-03-12-1648-rfbgzy","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"16:48:36","subject":"本公司董事會決議現金增資子公司PhiBio Therapeutics Inc.","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-03-12 16:48，「本公司董事會決議現金增資子公司PhiBio Therapeutics Inc.」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-03-12-1646-cievxs","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"16:46:57","subject":"本公司董事會決議召開114年股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-03-12 16:46，「本公司董事會決議召開114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-03-12-1646-xjq9hq","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"16:46:32","subject":"本公司董事會通過提案至股東常會討論發行限制員工權利新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-03-12 16:46，「本公司董事會通過提案至股東常會討論發行限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-03-12-1646-14e89kc","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"16:46:24","subject":"本公司董事會決議不繼續辦理113年股東常會通過現金增資私募普通股案。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-03-12 16:46，「本公司董事會決議不繼續辦理113年股東常會通過現金增資私募普通股案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-03-12-1646-1gd7p1r","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"16:46:07","subject":"本公司董事會決議通過113年度股東常會通過之有價證券私募案不繼續辦理","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-03-12 16:46，「本公司董事會決議通過113年度股東常會通過之有價證券私募案不繼續辦理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-03-12-1645-10f1fhr","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"16:45:54","subject":"公告本公司董事會決議召開114年股東常會及相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-03-12 16:45，「公告本公司董事會決議召開114年股東常會及相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-03-12-1645-1p16wuj","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"16:45:31","subject":"本公司董事會通過提案至股東常會討論辦理私募普通股（僅為股東常會例行性提案，目前並無確切規劃）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-03-12 16:45，「本公司董事會通過提案至股東常會討論辦理私募普通股（僅為股東常會例行性提案，目前並無確切規劃）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-03-12-1645-76x8ob","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"16:45:22","subject":"公告本公司董事會決議辦理114年度現金增資私募普通股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-03-12 16:45，「公告本公司董事會決議辦理114年度現金增資私募普通股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-03-12-1645-f1yp7a","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"16:45:04","subject":"本公司董事會通過提案至股東常會討論以詢價圈購或競價拍賣方式辦理現金增資發行普通股（僅為股東常會例行性提案，目前並無確切規劃）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-03-12 16:45，「本公司董事會通過提案至股東常會討論以詢價圈購或競價拍賣方式辦理現金增資發行普通股（僅為股東常會例行性提案，目前並無確切規」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-03-12-1644-1hku5w3","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"16:44:43","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-03-12 16:44，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-03-12-1644-wj1b9d","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"16:44:38","subject":"本公司董事會通過提案至股東常會討論辦理現金增資發行普通股參與發行海外存託憑證（僅為股東常會例行性提案，目前並無確切規劃）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-03-12 16:44，「本公司董事會通過提案至股東常會討論辦理現金增資發行普通股參與發行海外存託憑證（僅為股東常會例行性提案，目前並無確切規劃）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-03-12-1644-1ctgck9","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"16:44:10","subject":"本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-03-12 16:44，「本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6576-2025-03-12-1643-jfvmpj","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"16:43:43","subject":"本公司董事會決議通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-03-12 16:43，「本公司董事會決議通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7759-2025-03-12-1638-bwopfv","company_id":"7759","company":"視航生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"16:38:42","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：視航生醫（7759），2025-03-12 16:38，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6934-2025-03-12-1558-36lxn","company_id":"6934","company":"心誠鎂","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"15:58:11","subject":"公告本公司延長113年現金增資特定人繳款期間","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：心誠鎂（6934），2025-03-12 15:58，「公告本公司延長113年現金增資特定人繳款期間」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1565-2025-03-12-1552-1lxmxa7","company_id":"1565","company":"精華","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"15:52:18","subject":"公告本公司113年度合併財務報告業經董事會通過","clause":"第31款","fact_date":"2025-03-12","cite_as":"公開資訊觀測站重大訊息：精華（1565），2025-03-12 15:52，「公告本公司113年度合併財務報告業經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1565-2025-03-12-1549-1vgpz2i","company_id":"1565","company":"精華","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"15:49:38","subject":"公告本公司董事會決議召開民國114年股東常會","clause":"第17款","fact_date":"2025-03-12","cite_as":"公開資訊觀測站重大訊息：精華（1565），2025-03-12 15:49，「公告本公司董事會決議召開民國114年股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1565-2025-03-12-1546-1mvy42n","company_id":"1565","company":"精華","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"15:46:42","subject":"公告本公司董事會決議股利分派情形","clause":"第14款","fact_date":"2025-03-12","cite_as":"公開資訊觀測站重大訊息：精華（1565），2025-03-12 15:46，「公告本公司董事會決議股利分派情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6748-2025-03-12-1511-nxw5h9","company_id":"6748","company":"亞果生醫","market":"興櫃","industry":"生技醫療","date":"2025-03-12","time":"15:11:12","subject":"公告本公司膠原蛋白生物膜通過新加坡衛生科學局SMDR（Singapore Medical Device Register）核准上市","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：亞果生醫（6748），2025-03-12 15:11，「公告本公司膠原蛋白生物膜通過新加坡衛生科學局SMDR（Singapore Medical Device Register」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2025-03-12-1502-1j23cjx","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"15:02:44","subject":"本公司董事會決議召開114年股東常會相關事宜公告","clause":"第17款","fact_date":"2025-03-12","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2025-03-12 15:02，「本公司董事會決議召開114年股東常會相關事宜公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2025-03-12-1500-11wjw0o","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"15:00:05","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2025-03-12","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2025-03-12 15:00，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6615-2025-03-12-1453-1hku5w3","company_id":"6615","company":"慧智","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"14:53:51","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：慧智（6615），2025-03-12 14:53，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6794-2025-03-12-1437-146vvtd","company_id":"6794","company":"向榮生技","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"14:37:15","subject":"本公司開發中治療慢性腎臟病新藥ELIXCYTE，今日獲美國FDA審查通知授與新藥「快速審查認定」(Fast Track Designation)，有利加速此新藥未來申請美國藥證之時程。","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：向榮生技（6794），2025-03-12 14:37，「本公司開發中治療慢性腎臟病新藥ELIXCYTE，今日獲美國FDA審查通知授與新藥「快速審查認定」(Fast Track 」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-03-12-1358-g255cr","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"13:58:28","subject":"公告本公司董事會通過代理總經理案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-03-12 13:58，「公告本公司董事會通過代理總經理案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-03-12-1356-1nfj6ln","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"13:56:15","subject":"公告本公司109年度現金增資資金運用計畫變更","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-03-12 13:56，「公告本公司109年度現金增資資金運用計畫變更」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-03-12-1355-uc1g5w","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"13:55:59","subject":"本公司董事會決議庫藏股註銷減資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-03-12 13:55，「本公司董事會決議庫藏股註銷減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-03-12-1355-bwopfv","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"13:55:43","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-03-12 13:55，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-03-12-1355-1iqren5","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"13:55:26","subject":"公告董事會決議召開股東常會事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-03-12 13:55，「公告董事會決議召開股東常會事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-03-12-1355-3sk96k","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"13:55:10","subject":"公告本公司董事會決議發行限制員工權利新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-03-12 13:55，「公告本公司董事會決議發行限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-03-12-1354-1hku5w3","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-03-12","time":"13:54:49","subject":"公告本公司董事會通過113年度合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-03-12 13:54，「公告本公司董事會通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2025-03-12-0011-1bek91d","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2025-03-12","time":"00:11:29","subject":"公告本公司董事會決議召開股東會事宜(修正討論事項及停止過戶起始日期)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2025-03-12 00:11，「公告本公司董事會決議召開股東會事宜(修正討論事項及停止過戶起始日期)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}